TrademarkDir
TAZELPRI
LIVE

Serial Number

79227242

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jan 15, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TAZELPRI Trademark

Serial Number: 79227242 • Registration: 5537949

TAZELPRI is a trademark filed by NOVARTIS AG on January 15, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 15, 2018

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Cancellation Date

May 28, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Dec 13, 2021 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 14, 2021 CRCV
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 12, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 12, 2021 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 21, 2018 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 14, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Jun 2, 2018 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 16, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 16, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2018 CRFA
ASSIGNED TO LIE
Apr 19, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 11, 2018 TROA
REFUSAL PROCESSED BY IB
Mar 31, 2018 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 30, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2018 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 15, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 15, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 9, 2018 RFCR
NON-FINAL ACTION WRITTEN
Mar 8, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 3, 2018 MAFR
ASSIGNED TO EXAMINER
Feb 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 27, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 22, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 22, 2018 REPR

Related Trademarks

More from this Owner

BEXJUXI

BEXJUXI

VOBYXA

VOBYXA

VISANSTA

VISANSTA

VISANSTA

VISANSTA

VOBYXA

VOBYXA

CALIHE

CALIHE